Literature DB >> 20458824

Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway.

Konstantinos P Letsas1, Reinhold Weber, Claudia Herrera Siklody, Constantinos C Mihas, Jochem Stockinger, Thomas Blum, Dietrich Kalusche, Thomas Arentz.   

Abstract

OBJECTIVE: The present study aimed to evaluate the diagnostic value of specific ECG markers in the differentiation of common type atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) via a concealed accessory pathway.
METHODS: One hundred and ten ECGs with paroxysmal narrow QRS complex, short RP tachycardia were evaluated. Subjects with overt ventricular pre-excitation during sinus rhythm were excluded from the study. The mechanism of arrhythmia was established during the electrophysiological study and confirmed by the efficacy of radiofrequency ablation.
RESULTS: Of the 110 patients, 74 displayed common type AVNRT and 36 AVRT. Predictors of AVNRT were the presence of pseudo r'-waves in lead V1 [sensitivity 39.19%; specificity 97.14%; positive predictive value (PPV) 96.67%; negative predictive value (NPV) 43.04%] and pseudo S-waves in inferior leads (sensitivity 28.38%; specificity 94.29%; PPV 91.30%; NPV 38.37%). In the setting of visible P-waves, an RP interval < or =90 ms favoured the diagnosis of AVNRT (sensitivity 57.14%; specificity 80.65%). Predictors of AVRT were QRS alternans (sensitivity 50%; specificity 89.19%; PPV 69.23%; NPV 78.57%) as well as ST-segment alterations during tachycardia. The overall sensitivity, specificity, PPV and NPV of ST-segment depression for discriminating AVRT from AVNRT were 97.22%, 58.11%, 53.03%, 97.73%, respectively. Similarly, the sensitivity, specificity, PPV and NPV of ST-segment elevation in lead aVR were 94.44%, 58.11%, 52.31%, and 95.56%, respectively. Multiple logistic regression analysis showed that ST-segment depression [(odds ratio (OR): 12.67, 95% confidence interval (CI): 1.77-90.81, P = 0.011)] and QRS alternans (OR: 9.43, 95% CI: 1.38-64.37, P = 0.022) displayed the highest predictive ability favouring the diagnosis of AVRT.
CONCLUSIONS: Twelve-lead ECG parameters may help to differentiate the mechanism of supraventricular tachycardia prior to the ablation procedure.

Entities:  

Mesh:

Year:  2010        PMID: 20458824     DOI: 10.2143/AC.65.2.2047050

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  4 in total

1.  To decide medical therapy according to ECG criteria in patients with supraventricular tachycardia in emergency department: adenosine or diltiazem.

Authors:  Halil Dogan; Dogac Niyazi Ozucelik; Kurtulus Aciksari; Ilker Murat Caglar; Nursel Okutan; Mustafa Yazicioglu; Baris Murat Avyaci; Cem Simsek; Derya Ozasir; Tufan Akin Giray; Cem Ayan; Feridun Celikmen; Yıldız Okuturlar; Sezgin Sarikaya
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Differences in quality of life, anxiety and depression in patients with paroxysmal atrial fibrillation and common forms of atrioventricular reentry supraventricular tachycardias.

Authors:  Louiza Lioni; Konstantinos Vlachos; Konstantinos P Letsas; Michael Efremidis; Dimitrios Karlis; Dimitrios Asvestas; Vasilios Kareliotis; Sotirios Xydonas; Nikolaos Dimopoulos; Panagiotis Korantzopoulos; Athanasios Trikas; Antonios Sideris
Journal:  Indian Pacing Electrophysiol J       Date:  2014-10-06

3.  Electrocardiographic and Electrophysiologic Insights into Atrioventricular Nodal Re-entry Tachycardia: Diagnostic Update.

Authors:  Antoine Kossaify; Maya Zeeny
Journal:  Clin Med Insights Cardiol       Date:  2012-07-12

4.  Validation of Standard and New Criteria for the Differential Diagnosis of Narrow QRS Tachycardia in Children and Adolescents.

Authors:  Karol Deutsch; Sebastian Stec; Piotr Kukla; Aleksandra Morka; Marek Jastrzebski; Artur Baszko; Maciej Pitak; Janusz Sledz; Kamil Fijorek; Mariusz Mazij; Bartosz Ludwik; Marcin Gubaro; Leslaw Szydlowski
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.